Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Natural products for hyperlipidemia

July 11, 1997

ETA receptor blockade for counteracting effects of angiotensin II

July 11, 1997

n-3 fatty acids for prevention of restenosis

July 11, 1997

Immunological effects of HMG-CoA reductase inhibitors in humans

July 11, 1997

Magnesium implicated in death from cardiovascular disease

July 11, 1997

Cardiovascular effects of psychotropic drugs

July 11, 1997

c-fos gene is implicated in pain states

July 10, 1997

NK1 receptor antagonists for pain

July 10, 1997

SNX-111 and SNX-230, analgesic conopeptides and calcium channel blockers

July 10, 1997

Management of peripheral pain using neurotrophins

July 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...
Gensci-134: a long-acting growth hormone receptor agonist fusion protein
BioWorld Science
Gensci-134 (Genescience Pharmaceuticals Co. Ltd.) is a growth hormone receptor (GHR) agonist fusion protein that mimics the biological activity of growth hormone...